Florida Senate - 2019 COMMITTEE AMENDMENT Bill No. PCS (712656) for CS for SB 1528 Ì534426*Î534426 LEGISLATIVE ACTION Senate . House Comm: UNFAV . 04/18/2019 . . . . ————————————————————————————————————————————————————————————————— ————————————————————————————————————————————————————————————————— The Committee on Appropriations (Powell) recommended the following: 1 Senate Amendment to Amendment (858228) 2 3 Between lines 159 and 160 4 insert: 5 (b) The drug’s manufacturer has not had a report of an 6 investigator’s observation or a safety violation identified by 7 the United States Food and Drug Administration or an in-country 8 inspector within the previous 5 years;